Target intelligence / Profile preview

LIM domain binding protein 3 (LDB3)

Target
LDB3
Molecular classification
Other (PDZ domain-containing cytoskeletal adapter protein), Enigma subfamily protein
01

Overview

LIM domain binding protein 3 (LDB3), also known as Z-band alternatively spliced PDZ-motif protein (ZASP) or Cypher, is a cytoskeletal scaffolding protein strongly expressed in both cardiac and skeletal muscle[1][7][3][5]. It contains a PDZ domain at the N-terminal, allowing it to bind to α-actinin and other proteins involved in sarcomere assembly, and one or more C-terminal LIM domains (depending on the isoform), which mediate interactions with signaling molecules such as protein kinase C[1][5][7]. LDB3's primary biological role is to stabilize and maintain the structure of the Z-disc within muscle sarcomeres and to act as an adapter that integrates structural and signaling cues during muscle contraction and mechanical stress[1][5][3]. Mutations in LDB3 are causatively linked to several muscle diseases, notably dilated cardiomyopathy, left ventricular noncompaction, and myofibrillar myopathy[3][1][7]. There are no established direct drugs—which is typical for a structural cytoskeletal protein—but its mutation status is emerging as a genetic biomarker for patient stratification in hereditary cardiomyopathies[3].

Other names
ZASPCypherPDLIM6Protein cypherZ-band alternatively spliced PDZ-motif proteinOracleCMD1CCMD2LCMH24CMPD3CYPHERLDB3Z1LDB3Z4LVNC3MFM4
02

Biological functions

Maintenance of sarcomere/Z-disc integrityCytoskeletal organizationMuscle contractionMechanical stress sensingSignal integration in striated muscle
03

Disease associations

Cardiovascular disease (dilated cardiomyopathy, left ventricular non-compaction)Myofibrillar myopathy
04

Safety considerations

Potential for severe cardiac and musculoskeletal manifestations if disrupted
05

Biomarkers

Mutations used as genetic biomarker for some cardiomyopathies and myofibrillar myopathies[3][1]

Beyond the preview

Go deeper on LIM domain binding protein 3 (LDB3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIM domain binding protein 3 (LDB3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call